Daniel Patrick O'Day - 03 Aug 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Reporting relationship: Chairman & CEO, Director
Issuer ticker: GILD
Reported as of: 03 Aug 2026
Net transaction value: -$1,954,694
SEC form: 4
Accepted by SEC: 04 Aug 2026, 17:40:36 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy Kim by Power of Attorney for Daniel O'Day

Key filing fact

Daniel Patrick O'Day filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 04 Aug 2026.

Key facts

This page summarizes Daniel Patrick O'Day's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Aug 2026, 17:40.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: -$1,954,694.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001638643 Primary reporting owner

O'Day Daniel Patrick

Relationship: Chairman & CEO, Director
Address: 333 LAKESIDE DRIVE, FOSTER CITY
Signature: /s/ Amy Kim by Power of Attorney for Daniel O'Day
Signature date: 04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GILD transaction

Common Stock

Sale

Transaction value: $868,711
Shares: -6,700
Change %: -1.1%
Price: $129.66
Shares after: 600,433
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F2

GILD transaction

Common Stock

Sale

Transaction value: $1,007,177
Shares: -7,700
Change %: -1.3%
Price: $130.80
Shares after: 592,733
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F3

GILD transaction

Common Stock

Sale

Transaction value: $78,806
Shares: -600
Change %: -0.1%
Price: $131.34
Shares after: 592,133
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.

Footnote F2

Sale prices for the transactions reported range from $129.17 to $130.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F3

Sale prices for the transactions reported range from $130.18 to $131.17. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F4

Sale prices for the transactions reported range from $131.21 to $131.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.